The Human Tripeptide GHK-Cu in Prevention of Oxidative Stress and Degenerative Conditions of Aging
Phentermine is contraindicated in patients with cardiovascular disease, uncontrolled hypertension, hyperthyroidism, glaucoma, agitated states, history of drug abuse, and during or within 14 days of taking monoamine oxidase inhibitors (MAOIs)
However, it has limits
Xu et al., 2002), heavy metals (Rai et al., 2011), phosphate starvation (Shukla et al., 2015), salt (Reymond et al., 2000)
For a 10 mg vial: 1 mL gives 10 mg/mL (a 2.5 mg dose = 0.25 mL = 25 units), 2 mL gives 5 mg/mL (2.5 mg = 0.5 mL = 50 units), and 3 mL gives about 3.33 mg/mL (2.5 mg = 0.75 mL = 75 units)
The implications of such a development for addiction treatment, where treatment adherence is often the primary obstacle, are very significant